BIOMERICA INC
Nasdaq · In Vitro & In Vivo Diagnostic Substances
Company Overview
A concise company profile alongside the latest public filing activity.
Biomerica develops and manufactures diagnostic test kits used to detect gastrointestinal conditions, food sensitivities, diabetes, and other disorders, including tests for H. pylori infection and fecal occult blood. Its products are sold to clinical laboratories, physician offices, hospitals, and consumers through distributors in the United States and international markets.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Gary M. HuffDirector | Buy | $50K | 31,250at $1.60 | Aug 20, 2026 |
| MOATAZEDI DAVIDDirector | Buy | $16K | 10,000at $1.60 | Aug 26, 2026 |
| Chin EricDirector | Buy | $10K | 6,250at $1.60 | Aug 26, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable BMRA activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.